Iain has worked in the UK bioanalytical industry for 20 years. As part of his role, Iain oversees 90 scientists working in all areas of regulated bioanalysis and discovery services. Supporting a broad spectrum of analytical endpoints across the preclinical and clinical space, Iain’s team is well placed to develop and apply analytical strategy for almost any molecular scaffold. Iain is also Charles River’s representative to the European Bioanalysis Forum (EBF).
Bioanalytical Strategies Unlocked: Innovative Approaches to PK, Immunogenicity, and Biomarkers
In this webinar, our scientific experts will walk you through real-world case studies that illustrate how innovative bioanalytical approaches can help you overcome common hurdles in pharmacokinetics (PK), immunogenicity, and biomarker applications.
Watch the Replay
10 Years of Preclinical Microsampling: A Commitment to 4Rs
In this webinar, we share over a decade’s worth of in vivo data and laboratory learnings of CMS application, as well as look towards the future of preclinical and clinical microsampling.
Watch Now
Articles
- The Bioanalysis of Lipid Nanoparticle Delivery Systems (Eureka Blog)
- Quantitative HRMS in the age of Biologics – a commentary on the recent HRMS survey (Bioanalysis Zone)
Publications
- Feedback from the European Bioanalysis Forum liquid microsampling consortium: capillary liquid microsampling and assessment of homogeneity of the resultant samples (Bioanalysis)
- Feedback from the European Bioanalysis Forum liquid microsampling consortium: microsampling: assessing accuracy and precision of handheld pipettes and capillaries (Bioanalysis)
- Recommendations and discussion points on immunogenicity, biomarkers, automation/technology and protein–MS from the 2021 European Bioanalysis Forum Focus Workshops (Bioanalysis)
- Assessment of Whole Blood Stability and Blood/Plasma Distribution of Drugs (Handbook of LC-MS Bioanalysis: Best Practices, Experimental Protocols, and Regulations)
- Conference Report from the European Bioanalysis Forum Workshop: toward harmonized implementation of the ICH M10 guideline
- Immunocapture LC–MS(/MS) assays for biotherapeutic and biomarker proteins: the European Bioanalysis Forum continuing discussions on scientific and regulatory challenges